RESIST-TB
@resisttb.bsky.social
Research Excellence to Stop TB Resist: An initiative to promote and conduct research on MDR-TB treatment and prevention
resisttb.org
resisttb.org
Reposted by RESIST-TB
TB is making a comeback.
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com
Everything Is Tuberculosis
John Green, the #1 bestselling author of The Anthropocene Reviewed and a passionate advocate for global healthcare reform, tells a deeply human story illuminating the fight against the world’s deadlie...
everythingistb.com
November 27, 2025 at 2:38 PM
TB is making a comeback.
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com
Malnutrition and overcrowding create ideal conditions for tuberculosis to spread. It often takes years for symptoms to appear. Meanwhile, the disease spreads. There is no vaccine in the US. See John Green’s book, Everything is Tuberculosis
everythingistb.com
Reposted by RESIST-TB
Tuberculosis outbreak hits Labrador weeks after Inuit group decried funding loss
Tuberculosis outbreak hits Newfoundland and Labrador
Health officials in Newfoundland and Labrador are warning about an outbreak of tuberculosis within the Labrador Inuit Settlement Area.
www.ctvnews.ca
November 28, 2025 at 9:01 PM
Tuberculosis outbreak hits Labrador weeks after Inuit group decried funding loss
Reposted by RESIST-TB
11/27/1873 — b. Ellen N. La Motte, American nurse, #publichealth admin, journalist, writer, reformer, suffragist, activist. Early US nurse to treat WWI soldiers in Europe (1915); tuberculosis researcher + authority, anti-opium crusader #womenshistory #WomenInSTEM #MedSky #NurseSky #HistNursing #BOTD
November 27, 2025 at 7:51 PM
11/27/1873 — b. Ellen N. La Motte, American nurse, #publichealth admin, journalist, writer, reformer, suffragist, activist. Early US nurse to treat WWI soldiers in Europe (1915); tuberculosis researcher + authority, anti-opium crusader #womenshistory #WomenInSTEM #MedSky #NurseSky #HistNursing #BOTD
As part of the WHO consolidated guidelines on tuberculosis, the WHO has released new recommendations on tuberculosis and undernutrition. These new guidelines mark a critical step in addressing determinants as part of people-centered care under WHO’s End TB Strategy.
www.who.int/news/item/08...
www.who.int/news/item/08...
WHO releases new guidelines on tuberculosis and undernutrition
The World Health Organization (WHO) has released new recommendations on tuberculosis (TB) and undernutrition, as part of the WHO consolidated guidelines on tuberculosis. Module 6: tuberculosis and com...
www.who.int
November 5, 2025 at 8:37 PM
As part of the WHO consolidated guidelines on tuberculosis, the WHO has released new recommendations on tuberculosis and undernutrition. These new guidelines mark a critical step in addressing determinants as part of people-centered care under WHO’s End TB Strategy.
www.who.int/news/item/08...
www.who.int/news/item/08...
A study from Harvard T.H. Chan SPH and BU SPH provides some of the first estimates of the number of children who are expected to both develop and die from TB over the next decade in middle-low-income countries if the U.S. continues to cut funds. Give it a read!
hsph.harvard.edu/news/u-s-fun...
hsph.harvard.edu/news/u-s-fun...
U.S. funding cuts could result in nearly 9 million child tuberculosis cases, 1.5 million child deaths | Harvard T.H. Chan School of Public Health
A new Harvard Chan School and BUSPH study projects that U.S. funding cuts to global health aid will have a catastrophic effect on pediatric TB.
hsph.harvard.edu
November 5, 2025 at 8:35 PM
A study from Harvard T.H. Chan SPH and BU SPH provides some of the first estimates of the number of children who are expected to both develop and die from TB over the next decade in middle-low-income countries if the U.S. continues to cut funds. Give it a read!
hsph.harvard.edu/news/u-s-fun...
hsph.harvard.edu/news/u-s-fun...
Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/2bfb36489ccd...
mailchi.mp/2bfb36489ccd...
Stay up-to date on this month's TB developments!
mailchi.mp
November 5, 2025 at 8:32 PM
Check out our latest monthly newsletter and subscribe in the top left corner!
mailchi.mp/2bfb36489ccd...
mailchi.mp/2bfb36489ccd...
Sharing an upcoming youtube panel discussion on pediatric TB with John Green on November 13th 9am EST! No registration is needed - those interested can find the discussion on the @vlogbrothers youtube channel.
October 31, 2025 at 2:28 PM
Sharing an upcoming youtube panel discussion on pediatric TB with John Green on November 13th 9am EST! No registration is needed - those interested can find the discussion on the @vlogbrothers youtube channel.
Reposted by RESIST-TB
🔬 New in The Lancet Infectious Diseases! CLIME & collaborators highlight how to care for those exposed to MDR/RR-TB.
Key takeaways:
✅ Levofloxacin cuts TB risk ~60%
✅ Tuberculosis preventive treatment works
✅ Support & nutrition matter
📌 Read: doi.org/10.1016/S147...
#MDRTB #TBprevention #EndTB
Key takeaways:
✅ Levofloxacin cuts TB risk ~60%
✅ Tuberculosis preventive treatment works
✅ Support & nutrition matter
📌 Read: doi.org/10.1016/S147...
#MDRTB #TBprevention #EndTB
July 28, 2025 at 2:01 PM
🔬 New in The Lancet Infectious Diseases! CLIME & collaborators highlight how to care for those exposed to MDR/RR-TB.
Key takeaways:
✅ Levofloxacin cuts TB risk ~60%
✅ Tuberculosis preventive treatment works
✅ Support & nutrition matter
📌 Read: doi.org/10.1016/S147...
#MDRTB #TBprevention #EndTB
Key takeaways:
✅ Levofloxacin cuts TB risk ~60%
✅ Tuberculosis preventive treatment works
✅ Support & nutrition matter
📌 Read: doi.org/10.1016/S147...
#MDRTB #TBprevention #EndTB
Reposted by RESIST-TB
At APOPO, heroes come in all sizes — some are rats! Our #HeroRATs use their incredible sense of smell to detect landmines and tuberculosis, keeping communities safe.
Discover how these little heroes make a big impact → bit.ly/43rwNEH
#APOPO #AnimalHeroes #SavingLives
Discover how these little heroes make a big impact → bit.ly/43rwNEH
#APOPO #AnimalHeroes #SavingLives
October 21, 2025 at 5:10 PM
At APOPO, heroes come in all sizes — some are rats! Our #HeroRATs use their incredible sense of smell to detect landmines and tuberculosis, keeping communities safe.
Discover how these little heroes make a big impact → bit.ly/43rwNEH
#APOPO #AnimalHeroes #SavingLives
Discover how these little heroes make a big impact → bit.ly/43rwNEH
#APOPO #AnimalHeroes #SavingLives
Reposted by RESIST-TB
Reposted by RESIST-TB
Measles, polio, tuberculosis: what’s causing spikes in infectious diseases? www.nature.com/articles/d41...
Measles, polio, tuberculosis: what’s causing spikes in infectious diseases?
The huge power of vaccines is being diluted by hesitancy, funding cuts and conflict.
www.nature.com
October 22, 2025 at 1:45 PM
Measles, polio, tuberculosis: what’s causing spikes in infectious diseases? www.nature.com/articles/d41...
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/6663c4590678...
mailchi.mp/6663c4590678...
Stay up-to date on this month's TB developments!
mailchi.mp
October 6, 2025 at 7:43 PM
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/6663c4590678...
mailchi.mp/6663c4590678...
Reposted by RESIST-TB
Excited to share Wendy Le Mouëllic’s PhD work, now published in @pnas.org!
It reveals that M. tuberculosis depends on inorganic sulfate import to survive inside host cells—fueling essential processes such as redox balance and stress resistance.
Huge congrats to Wendy & colleagues!
shorturl.at/WbFQC
It reveals that M. tuberculosis depends on inorganic sulfate import to survive inside host cells—fueling essential processes such as redox balance and stress resistance.
Huge congrats to Wendy & colleagues!
shorturl.at/WbFQC
Inorganic sulfate is critical for Mycobacterium tuberculosis lung tissue colonization and redox balance | PNAS
Tuberculosis remains the deadliest infectious disease caused by a single pathogen,
highlighting the urgent need for novel therapies. A deeper under...
www.pnas.org
September 23, 2025 at 3:32 AM
Excited to share Wendy Le Mouëllic’s PhD work, now published in @pnas.org!
It reveals that M. tuberculosis depends on inorganic sulfate import to survive inside host cells—fueling essential processes such as redox balance and stress resistance.
Huge congrats to Wendy & colleagues!
shorturl.at/WbFQC
It reveals that M. tuberculosis depends on inorganic sulfate import to survive inside host cells—fueling essential processes such as redox balance and stress resistance.
Huge congrats to Wendy & colleagues!
shorturl.at/WbFQC
Reposted by RESIST-TB
The Gates Foundation will give almost one billion dollars to the Global Fund to Fight AIDS, Tuberculosis and Malaria, philanthropist Bill Gates announced on Monday as he urged governments to reverse global health funding cuts.
www.reuters.com/business/hea...
www.reuters.com/business/hea...
Bill Gates pledges $912 million to global disease fight, urges governments to step up
The Gates Foundation will give $912 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria, philanthropist Bill Gates announced on Monday as he urged governments to reverse global health funding cuts.
www.reuters.com
September 23, 2025 at 2:49 AM
The Gates Foundation will give almost one billion dollars to the Global Fund to Fight AIDS, Tuberculosis and Malaria, philanthropist Bill Gates announced on Monday as he urged governments to reverse global health funding cuts.
www.reuters.com/business/hea...
www.reuters.com/business/hea...
Reposted by RESIST-TB
The Gates Foundation will give $912 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria, philanthropist Bill Gates announced Monday as he urged governments to reverse global cuts to health funding.
Bill Gates pledges $912 million to health aid, urging countries to reverse cuts
Speaking at an event in New York, Gates said the world was at a crossroads, with millions of children at risk of dying if funding drops too steeply.
ebx.sh
September 23, 2025 at 5:42 AM
The Gates Foundation will give $912 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria, philanthropist Bill Gates announced Monday as he urged governments to reverse global cuts to health funding.
Join us October 2nd at 9 am EST for our next panel webinar to learn more about Long-Acting Injectables for TB treatment!
Register here: harvard.zoom.us/webinar/regi...
Register here: harvard.zoom.us/webinar/regi...
SAVE THE DATE: Panel on Long-Acting Injectables for TB Treatment
mailchi.mp
September 26, 2025 at 12:25 AM
Join us October 2nd at 9 am EST for our next panel webinar to learn more about Long-Acting Injectables for TB treatment!
Register here: harvard.zoom.us/webinar/regi...
Register here: harvard.zoom.us/webinar/regi...
Reposted by RESIST-TB
Dr. Sue Swindells co-authored this paper in @cidjournal.bsky.social on the use of levofloxacin (and other novel regimens) for MDR TB prevention. Congrats!
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
Preventing multidrug resistant tuberculosis: the dawn of a new era
Treatment of multidrug-resistant (MDR) TB infection is a global health priority.The World Health Organization recommends use of levofloxacin in MDR-TB expo
academic.oup.com
August 18, 2025 at 2:55 PM
Dr. Sue Swindells co-authored this paper in @cidjournal.bsky.social on the use of levofloxacin (and other novel regimens) for MDR TB prevention. Congrats!
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
Reposted by RESIST-TB
Research saves lives. From breakthroughs in vaccines to pioneering MDR-TB treatment, studies have fueled decades of progress in global health. But funding cuts threaten to undo this progress.
We know research isn’t optional, it’s essential to advancing care
Read more: https://bit.ly/45QHQYx
We know research isn’t optional, it’s essential to advancing care
Read more: https://bit.ly/45QHQYx
What Research Funding Cuts Mean for the Future of Health Care
U.S. government cuts to research funding harm medical advancements, cost jobs, and will ultimately hurt millions of people around the world.
bit.ly
August 27, 2025 at 10:14 PM
Research saves lives. From breakthroughs in vaccines to pioneering MDR-TB treatment, studies have fueled decades of progress in global health. But funding cuts threaten to undo this progress.
We know research isn’t optional, it’s essential to advancing care
Read more: https://bit.ly/45QHQYx
We know research isn’t optional, it’s essential to advancing care
Read more: https://bit.ly/45QHQYx
Reposted by RESIST-TB
Game-changer for people with MDR-TB: The cost of the most widely recommended treatment has dropped below $300 for the first time.
Thanks to Stop TB's Global Drug Facility, price cuts on key DR-TB medicines will make lifesaving care more affordable and accessible worldwide: https://bit.ly/4pbkMg4
Thanks to Stop TB's Global Drug Facility, price cuts on key DR-TB medicines will make lifesaving care more affordable and accessible worldwide: https://bit.ly/4pbkMg4
Breaking News: Historical Drop of DR-TB Treatment Cost Below $300 After Third Major Cut in 2025 by Stop TB’s Global Drug Facility | Stop TB Partnership
bit.ly
September 4, 2025 at 12:49 AM
Game-changer for people with MDR-TB: The cost of the most widely recommended treatment has dropped below $300 for the first time.
Thanks to Stop TB's Global Drug Facility, price cuts on key DR-TB medicines will make lifesaving care more affordable and accessible worldwide: https://bit.ly/4pbkMg4
Thanks to Stop TB's Global Drug Facility, price cuts on key DR-TB medicines will make lifesaving care more affordable and accessible worldwide: https://bit.ly/4pbkMg4
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/99f793ecf502...
mailchi.mp/99f793ecf502...
Stay up-to date on this month's TB developments!
mailchi.mp
September 8, 2025 at 4:40 PM
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/99f793ecf502...
mailchi.mp/99f793ecf502...
Please join us September 11 at 8 am EST to learn more about John Green's NYT bestselling book "Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection"!
Register here: harvard.zoom.us/webinar/regi...
Register here: harvard.zoom.us/webinar/regi...
YOU'RE INVITED: Everything Is Tuberculosis With John Green!
mailchi.mp
September 5, 2025 at 2:39 AM
Please join us September 11 at 8 am EST to learn more about John Green's NYT bestselling book "Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection"!
Register here: harvard.zoom.us/webinar/regi...
Register here: harvard.zoom.us/webinar/regi...
Join us September 11 at 8 am EST to learn more about John Green's NYT bestselling book "Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection"!
mailchi.mp/bd72f27ae501...
mailchi.mp/bd72f27ae501...
SAVE THE DATE: "Everything Is Tuberculosis" With John Green
mailchi.mp
August 15, 2025 at 4:02 PM
Join us September 11 at 8 am EST to learn more about John Green's NYT bestselling book "Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection"!
mailchi.mp/bd72f27ae501...
mailchi.mp/bd72f27ae501...
Reposted by RESIST-TB
#IDsky
#Medsky
Check out this interesting case of MDR TB treated with BPaL (bedaquiline, pretomanid, and linezolid) for 26 weeks.
Read about how this decision was made and about advancements in MDR and XDR TB treatments here! 👇
www.ppidjournal.com/doi10-55636-...
#Medsky
Check out this interesting case of MDR TB treated with BPaL (bedaquiline, pretomanid, and linezolid) for 26 weeks.
Read about how this decision was made and about advancements in MDR and XDR TB treatments here! 👇
www.ppidjournal.com/doi10-55636-...
A Case of Multidrug-Resistant Tuberculosis in a Young Patient With Rheumatoid Arthritis - Private Practice Infectious Disease
Multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) pose significant challenges to global health. We present a 37-year-old male with rheumatoid arthritis who ...
www.ppidjournal.com
January 18, 2025 at 7:17 PM
#IDsky
#Medsky
Check out this interesting case of MDR TB treated with BPaL (bedaquiline, pretomanid, and linezolid) for 26 weeks.
Read about how this decision was made and about advancements in MDR and XDR TB treatments here! 👇
www.ppidjournal.com/doi10-55636-...
#Medsky
Check out this interesting case of MDR TB treated with BPaL (bedaquiline, pretomanid, and linezolid) for 26 weeks.
Read about how this decision was made and about advancements in MDR and XDR TB treatments here! 👇
www.ppidjournal.com/doi10-55636-...
Reposted by RESIST-TB
Did you know tuberculosis gave America the cowboy hat? "Everything Is Tuberculosis" author @johngreensbluesky.bsky.social explains
August 5, 2025 at 5:52 PM
Did you know tuberculosis gave America the cowboy hat? "Everything Is Tuberculosis" author @johngreensbluesky.bsky.social explains
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/daa33c7ea696...
mailchi.mp/daa33c7ea696...
Stay up-to date on this month's TB developments!
mailchi.mp
August 13, 2025 at 8:16 PM
Check out our latest newsletter and subscribe in the top left corner!
mailchi.mp/daa33c7ea696...
mailchi.mp/daa33c7ea696...